<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200120046200N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-12</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of companion and midwife presence during the mother-and-baby skin-to-skin contact</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of companion and midwife presence during the mother-and-baby skin-to-skin contact on pain and maternal anxiety and neonate physiological indices</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>92</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/46616</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Random allocation for placement in the intervention and control group is done by random block method in four blocks and with allocation software: In this way, by entering the research units in the plan, by referring to the four blocks (letter A belongs to the intervention group and letter B belongs to the control group), the research units are assigned to the intervention and control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Maternal pain and anxiety and assessment of neonatal physiological parameters.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Immediately after birth, the baby will be placed on the maternal abdomen, and dried, and the Apgar scores will be determined. If conditions will be appropriate for the skin-to-skin contact (SSC), the cord will be cut off after 3 minutes, and the head and back should be covered with a warm towel. The infant's axillary temperature, the saturation pressure oxygen (SPo2), and the heart rate (HR) will be measured using a mercury thermometer and a pulse oximeter, respectively. The maternal pain and anxiety will be evaluated on a visual analog scale, then, SSC is uninterrupted, and the baby will be placed on the mom's chest, (Baby's head between breasts), and then SSC will begin. This contact will continue at least one hour. In the intervention group, the mother's companion will perform SSC, while the researcher (midwife) will be present and will monitor the work process.The infant's axillary temperature, blood oxygen saturation percentage, infant heart rate, pain and maternal anxiety will be measured at 30, 60 and 90 minutes after the onset of skin contact. Intervention 2: Control group: Immediately after birth, the baby will be placed on the maternal abdomen, and dried, and the Apgar scores will be determined. If conditions will be appropriate for the skin-to-skin contact (SSC), the cord will be cut off after 3 minutes, and the head and back should be covered with a warm towel. The infant's axillary temperature, the saturation pressure oxygen (SPo2), and the heart rate (HR) will be measured using a mercury thermometer and a pulse oximeter, respectively. The maternal pain and anxiety will be evaluated on a visual analog scale, then, SSC is uninterrupted, and the baby will be placed on the mom's chest, (Baby's head between breasts), and then SSC will begin. This contact will continue for at least one hour. In this group,a midwife does skin contact. The infant's axillary temperature, blood oxygen saturation percentage, infant heart rate, pain and maternal anxiety will be measured at 30, 60 and 90 minutes after the onset of skin contact.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It will be decided in the future.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Seyedeh Saeedeh Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery.,  Rashid Yasimi Street., above Vanak Square., Valiasr Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۹۶۷۱۳۸۸۳</zip>
        <telephone>+98 21 4365 1807</telephone>
        <email>Saideh.musavi@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyedeh Saeedeh Mousavi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Nursing and Midwifery.,  Rashid Yasimi Street., above Vanak Square., Valiasr Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۱۹۹۶۷۱۳۸۸۳</zip>
        <telephone>+98 21 4365 1807</telephone>
        <email>mousavi.ss@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Single pregnancy and wanted pregnancy
Natural delivery
Lack of obstetrics complications (such as gestational hypertension, gestational diabetes, prolonged or suspended labor, and fetal distress)
No history of maternal medical diseases or mental illnesses
Birth weight ≥2500
One minute Apgar score ≥ 7
No medical problem and abnormality in the baby
Gestational age ≥ 37 weeks
No manual removal of placenta
No analgesia during labor
No prohibition of breastfeeding
Having a lady companion</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Maternal unwillingness to participate in  the research
Third-or fourth-degree perineal lacerations
Postpartum hemorrhage
Five minute Apgar score &lt; 7
Anything interrupting skin-to-skin contact</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Immediately after birth, the baby will be placed on the maternal abdomen, and dried, and the Apgar scores will be determined. If conditions will be appropriate for the skin-to-skin contact (SSC), the cord will be cut off after 3 minutes, and the head and back should be covered with a warm towel. The infant's axillary temperature, the saturation pressure oxygen (SPo2), and the heart rate (HR) will be measured using a mercury thermometer and a pulse oximeter, respectively. The maternal pain and anxiety will be evaluated on a visual analog scale, then, SSC is uninterrupted, and the baby will be placed on the mom's chest, (Baby's head between breasts), and then SSC will begin. This contact will continue at least one hour. In the intervention group, the mother's companion will perform SSC, while the researcher (midwife) will be present and will monitor the work process.The infant's axillary temperature, blood oxygen saturation percentage, infant heart rate, pain and maternal anxiety will be measured at 30, 60 and 90 minutes after the onset of skin contact.</i_keyword>
      <i_keyword>Control group: Immediately after birth, the baby will be placed on the maternal abdomen, and dried, and the Apgar scores will be determined. If conditions will be appropriate for the skin-to-skin contact (SSC), the cord will be cut off after 3 minutes, and the head and back should be covered with a warm towel. The infant's axillary temperature, the saturation pressure oxygen (SPo2), and the heart rate (HR) will be measured using a mercury thermometer and a pulse oximeter, respectively. The maternal pain and anxiety will be evaluated on a visual analog scale, then, SSC is uninterrupted, and the baby will be placed on the mom's chest, (Baby's head between breasts), and then SSC will begin. This contact will continue for at least one hour. In this group,a midwife does skin contact. The infant's axillary temperature, blood oxygen saturation percentage, infant heart rate, pain and maternal anxiety will be measured at 30, 60 and 90 minutes after the onset of skin contact.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mother's pain. Timepoint: Before intervention, 30, 60 and 90 minutes after beginning skin to skin contact. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
      <prim_outcome>Infant temperature. Timepoint: Before intervention, 30, 60 and 90 minutes after beginning skin to skin contact. Method of measurement: Mercury thermometer.</prim_outcome>
      <prim_outcome>Infant heart rate. Timepoint: Before intervention, 30, 60 and 90 minutes after beginning skin to skin contact. Method of measurement: Pulse Oximeter device.</prim_outcome>
      <prim_outcome>Percentage of oxygen saturation of the infant's blood. Timepoint: Before intervention, 30, 60 and 90 minutes after beginning skin to skin contact. Method of measurement: Pulse Oximeter device.</prim_outcome>
      <prim_outcome>Mother's anxiety. Timepoint: Before intervention, 30, 60 and 90 minutes after beginning skin to skin contact. Method of measurement: Visual Analogue Scale (VAS).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-03-15</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>ّّFifth floor, Headquarters.,  Iran University of Medical Sciences., Hemmat Highway between Chamran and Sheikh Fazlullah Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
